877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Experimental cancer drugs, matrixscientific.com, Three-membered rings, Antineoplastic and immunomodulating drugs, Organofluorides, Tetracyclic compounds

Categories

Antineoplastic drugs (1)
Cyclic compounds (1)
Cycloalkanes (1)
Cyclopropanes (1)
Halides (1)
Organohalides (1)
Pharmaceuticals (1)
Piperazines (1)
Six-membered rings (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.

Related Results:
2,6-DIMETHYLQUINOLINE (877-43-0)  
2,6-dimethyl quinoline
4-Aminoquinoline (578-68-7)  
4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections. Examples include amodiaquine, chloroquine, and hydroxychloroquine.
6-Methoxyquinoline (5263-87-6)  
6-methoxyquinoline hydrochloride
PYRAZINE (290-37-9)  
Pyrazine is a heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine is a symmetrical molecule with point group D2h. Pyrazine is less basic than pyridine, pyridazine and pyrimidine.
2,5-DIMETHYLPYRAZINE (123-32-0)  
2,5-DMP  ·  2,6-dimethylpyrazine
Related searches
Polycyclic organic compounds
Experimental cancer drugs
matrixscientific.com
Three-membered rings
Antineoplastic and immunomodulating drugs
Organofluorides
Tetracyclic compounds
Next Page >